<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Orgenesis Inc.

    Orgenesis Inc.

    Orgenesis is a vertically-integrated biopharmaceutical company with unique experti...

    Orgenesis is a vertically-integrated biopharmac...

    Filing Type:    PU
    IntriCon Corporation

    IntriCon Corporation

    For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...

    For more than 40 years, IntriCon has been meeti...

    Filing Type:    PU
    MeiraGTx Holdings plc

    MeiraGTx Holdings plc

    We are a vertically integrated, clinical stage gene therapy company with four ongo...

    We are a vertically integrated, clinical stage ...

    Filing Type:    PU
    Adaptimmune Therapeutics PLC

    Adaptimmune Therapeutics PLC

    Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer ...

    Adaptimmune is a leader in TCR T-cell therapy, ...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics, Inc.

    Aquestive Therapeutics is a specialty pharmaceutical company that advances and com...

    Aquestive Therapeutics is a specialty pharmaceu...

    Filing Type:    PU
    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Bellicum Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the ...

    Salarius Pharmaceuticals, Inc. is a clinical-st...

    Filing Type:    PU
    Heat Biologics, Inc.

    Heat Biologics, Inc.

    Heat Biologics a biopharmaceutical company that develops immunotherapies with the ...

    Heat Biologics a biopharmaceutical company that...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.